2-Arylquinolines as novel anticancer agents with dual EGFR/FAK kinase inhibitory activity: synthesis, biological evaluation, and molecular modelling insights. - Elbadawi MM; Eldehna WM; Abd El-Hafeez AA; Somaa WR; Albohy A; Al-Rashood ST; Agama KK; Elkaeed EB; Ghosh P; Pommier Y; Abe M (Journal of enzyme inhibition and medicinal chemistry, 2022)